Results of a blind, randomized, placebo-controlled trial show feasibility and efficacy of adventitial progenitor cell transplantation in a swine model of reperfused myocardial infarction.
Event: ESC Congress 2017
Topic: Stem cells and cell therapy
Session: Cardiac regeneration and repair
ESC 365 is supported by
